Moffitt study links methylmalonic acid to weakening of immune cells in lung cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Apr-2025 01:08 ET (23-Apr-2025 05:08 GMT/UTC)
Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a revolutionary injectable granular filler that could transform the way diabetic wounds are treated, potentially improving patient outcomes. The groundbreaking study, published in ACS Nano, introduced an innovative approach about using specialized porous dermal fillers that accelerate tissue healing and regeneration.